← Back to Clinical Trials
Recruiting NCT07324343

NCT07324343 Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07324343
Status Recruiting
Phase —
Sponsor Istanbul University - Cerrahpasa
Condition Shoulder Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 116 participants
Start Date 2025-09-01
Primary Completion 2027-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Questionnaire ValidationPatient Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 116 participants in total. It began in 2025-09-01 with a primary completion date of 2027-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary aim of this study is to determine the clinical effectiveness of patient education alone in individuals with rotator cuff-related shoulder pain and to identify which patient subgroups benefit more from this approach. In addition, the translation and cultural adaptation of the "Patient Knowledge Questionnaire (PKQ-RCRSP)" into Turkish will be carried out to measure the level of patient knowledge regarding patient education.

Eligibility Criteria

Inclusion Criteria: * Individuals aged 18-65 years * Shoulder pain persisting for at least 4 weeks * Diagnosed by an orthopedic physician with impingement, subacromial bursitis, rotator cuff (RC) tendinopathy, or partial tear * Activity-related pain ≥3 on the NPRS * Cognitively able to understand the education and provide written informed consent Exclusion Criteria: * History of shoulder surgery * Diagnosis of frozen shoulder, full-thickness or massive rotator cuff (RC) tear, or instability * Presence of neurological or psychiatric conditions that prevent exercise * History of physical therapy-rehabilitation or injection treatment within the past 6 months * Pain persisting for more than 12 months

Contact & Investigator

Central Contact

Merve KOYUNCU CENİKLİ Research asistant, MSc

✉ merve.cenikli@iuc.edu.tr

📞 +90(0212) 414 15 00

Frequently Asked Questions

Who can join the NCT07324343 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Shoulder Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07324343 currently recruiting?

Yes, NCT07324343 is actively recruiting participants. Contact the research team at merve.cenikli@iuc.edu.tr for enrollment information.

Where is the NCT07324343 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07324343 clinical trial?

NCT07324343 is sponsored by Istanbul University - Cerrahpasa. The trial plans to enroll 116 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology